Search research articles
Contact Us
Filters
Showing results (451-460 of 498) with videos related to
Page
of 50
Sort By:
The Journal of Biological Chemistry
|
June 10, 2026
Correction: F2,6BP restores mitochondrial genome integrity in Huntington's disease
Anirban Chakraborty, Santi M Mandal, Mikita Mankevich, et al.
Frontiers in Oncology
|
April 4, 2022
Modulation of ERCC1-XPF Heterodimerization Inhibition <i>via</i> Structural Modification of Small Molecule Inhibitor Side-Chains
Claudia Weilbeer, David Jay, James C Donnelly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 1998
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study
S Mani, J W Kugler, D F Sciortino, et al.
Oncogene
|
June 24, 2023
Critical role of antioxidant programs in enzalutamide-resistant prostate cancer
Eliot B Blatt, Karla Parra, Antje Neeb, et al.
Molecular Cell
|
March 8, 2005
The molecular architecture of the mammalian DNA repair enzyme, polynucleotide kinase
Nina K Bernstein, R Scott Williams, Melissa L Rakovszky, et al.
Nucleic Acids Research
|
August 10, 2011
Phosphorylation of polynucleotide kinase/ phosphatase by DNA-dependent protein kinase and ataxia-telangiectasia mutated regulates its association with sites of DNA damage
Angela E Zolner, Ismail Abdou, Ruiqiong Ye, et al.
Vaccine
|
March 30, 2019
Avoiding preventable deaths: The scourge of counterfeit rabies vaccines
Emma Taylor, Ashley C Banyard, Hervé Bourhy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer
C M Rudin, J Holmlund, G F Fleming, et al.
The Journal of Physical Chemistry. A
|
February 20, 2015
Detection and Identification of the Keto-Hydroperoxide (HOOCH2OCHO) and Other Intermediates during Low-Temperature Oxidation of Dimethyl Ether
Kai Moshammer, Ahren W Jasper, Denisia M Popolan-Vaida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer
N J Vogelzang, S Mani, R L Schilsky, et al.
Page
of 50
Search research articles
Search
Showing results (451-460 of 498) with videos related to
Sort By:
Page
of 50
The Journal of Biological Chemistry
|
June 10, 2026
Correction: F2,6BP restores mitochondrial genome integrity in Huntington's disease
Anirban Chakraborty, Santi M Mandal, Mikita Mankevich, et al.
Frontiers in Oncology
|
April 4, 2022
Modulation of ERCC1-XPF Heterodimerization Inhibition <i>via</i> Structural Modification of Small Molecule Inhibitor Side-Chains
Claudia Weilbeer, David Jay, James C Donnelly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 1998
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study
S Mani, J W Kugler, D F Sciortino, et al.
Oncogene
|
June 24, 2023
Critical role of antioxidant programs in enzalutamide-resistant prostate cancer
Eliot B Blatt, Karla Parra, Antje Neeb, et al.
Molecular Cell
|
March 8, 2005
The molecular architecture of the mammalian DNA repair enzyme, polynucleotide kinase
Nina K Bernstein, R Scott Williams, Melissa L Rakovszky, et al.
Nucleic Acids Research
|
August 10, 2011
Phosphorylation of polynucleotide kinase/ phosphatase by DNA-dependent protein kinase and ataxia-telangiectasia mutated regulates its association with sites of DNA damage
Angela E Zolner, Ismail Abdou, Ruiqiong Ye, et al.
Vaccine
|
March 30, 2019
Avoiding preventable deaths: The scourge of counterfeit rabies vaccines
Emma Taylor, Ashley C Banyard, Hervé Bourhy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer
C M Rudin, J Holmlund, G F Fleming, et al.
The Journal of Physical Chemistry. A
|
February 20, 2015
Detection and Identification of the Keto-Hydroperoxide (HOOCH2OCHO) and Other Intermediates during Low-Temperature Oxidation of Dimethyl Ether
Kai Moshammer, Ahren W Jasper, Denisia M Popolan-Vaida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer
N J Vogelzang, S Mani, R L Schilsky, et al.
Page
of 50